HealthTimes

Health News

Every new baby in the UK to receive DNA testing

Michael Gwarisa

Every baby in the UK will have their DNA tested under a new 10-year plan for the NHS. The whole-genome sequencing will screen for hundreds of diseases and allow people to “leapfrog” killer illnesses, according to the Health Secretary, Wes Streeting. Speaking to the Telegraph, he revealed plans to move the NHS towards a model of sickness

Read More
Features

Humans Age Faster at 2 Specific Times in Their Life, Study Finds

Michael Gwarisa

Getting older might seem like a slow, inevitable process — but new research suggests that aging can actually arrive in sudden, dramatic bursts. If you’ve ever looked in the mirror one morning and thought, “Did I age overnight?” — it turns out you might not be imagining it. A groundbreaking study published in Nature Aging

Read More
OP ED

Fixing the Waste Below Us — Why Zimbabwe Must Rethink Septic Tank Sanitation

Michael Gwarisa

By Golden Musosi In Zimbabwe’s rapidly urbanizing spaces, where population growth often outpaces infrastructure, sanitation has become a ticking time bomb. One of the most overlooked yet critical elements of urban health is the septic tank system — a decentralized wastewater treatment solution that, if mismanaged, can silently unleash widespread disease and environmental damage. A

Read More
Health News OP ED

Five Things Every Woman Should Know About Menopause

Michael Gwarisa

By Karen Bester Being a woman isn’t always easy. From a young age, we’re told half-truths and vague warnings about the changes our bodies will face. From periods to pregnancy and eventually menopause. In South Africa in particular, many women still don’t receive the right education about this important and inevitable phase of life, according

Read More
Global Health Health News HIV/AIDS

FDA approves twice-a-year injection for HIV prevention

Michael Gwarisa

CNN — A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.

Read More
Health News

Avenues Clinic Rallies Youth Toward STEM, Breaking Perceived Limitations

Michael Gwarisa

By Michael Gwarisa In an era fraught with job uncertainty, driven by advances in artificial intelligence and a contracting employment market, the Avenues Clinic in Harare recently took an inspiring step to empower its young men. On June 14, more than 100 male students from Harare High School, Allan Wilson, Mufakose High School, and others

Read More
Health News

Africa’s Healthcare Gets Boost as Merck Foundation-Trained Doctors Fill Specialist Gap

Michael Gwarisa

By Kuda Pembere Following training in critical specialties through scholarships awarded by the Merck Foundation, African doctors are now seeing around 1,000 patients each month, significantly reducing the disease burden in their communities. Previously, many of these patients had nowhere to go for specialized care. Speaking at the Merck Foundation First Lades Initiative in Dubai,

Read More